Fibromyalgia Patients Taking MitoQ Reported Less Pain, Improved Memory in Online Study

Fibromyalgia Patients Taking MitoQ Reported Less Pain, Improved Memory in Online Study
After six weeks of treatment with the mitochondrial supplement MitoQ, fibromyalgia patients said they had reduced pain and improved memory, according to a study conducted entirely online. The study, The influence of MitoQ on symptoms and cognition in fibromyalgia, myalgic encephalomyelitis and chronic fatigue, represents a new way of performing research, largely omitting the costs associated with traditional clinical trials. The trial was conducted by Cort Johnson at Health Rising, an information site for patients with fibromyalgia, and Joshua Grant, a neuroscientist at Mendus.org, an online platform where people with health conditions can help create their own research studies. In contrast to traditional studies, patients measured and reported all their symptoms and could also individually manage their treatment regimens. However, the study was performed just as a traditional clinical trial: Patients were randomized to receive either supplements or a placebo, and both patients and scientists managing the study did not know who was assigned to the treatments. MitoQ is a supplement to improve mitochondrial function by providing more of the antioxidant Coenzyme Q10. The supplements are designed to improve the uptake of the molecule when taken in a capsule form. The study is the largest conducted by Mendus.org to date, and was in part made possible by MitoQ, which provided patients with their product or a placebo supplement  which was visually identical to the MitoQ capsules. A total of 47 fibromyalgi
Subscribe or to access all post and page content.